Bigul

Compliance Certificate For The Half Year Ended 31St March, 2017.

Pursuant to the provisions of Regulation 7(3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we are enclosing herewith the certificate duly signed by Skyline Financial Services Pvt. Ltd., Share Transfer Agent and Company Secretary of Panacea Biotec Ltd. for the half year ended 31st March, 2017 in compliance of Regulation 7(2) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.
22-04-2017
Bigul

Shareholding for the Period Ended March 31, 2017

Panacea Biotec Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click here
22-04-2017
Bigul

Statement Of The Investor Complaints For The Quarter Ended 31St March, 2017

Pursuant to regulation 13(3) of SEBI (LODR) Regulations, 2015, statement of the Investor Complaints for the quarter ended 31st March, 2017
21-04-2017
Bigul

Narayana Hrudayalaya inks pact with Panacea Biotec

Narayana Hrudayalaya has entered into an agreement with Panacea Biotec to fully acquire its subsidiary NewRise Healthcare for an enterprise value of Rs 180 crore. The company has entered into a...
21-04-2017
Bigul

Updates

Ref.: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Sub.: Definitive Agreement entered into for sale of 100% stake in the Subsidiary Company NewRise Healthcare Pvt. Ltd.
21-04-2017
Bigul

Updates

Copy of the notice for the attention of equity shareholders of the Company in respect of proposed transfer of equity shares of the Company to DEMAT Account of Investor Education and Protection Fund ('IEPF') Authority, published on 30th March, 2017 in Business Standard newspaper (All Editions).
30-03-2017
Bigul

Press Release

Panacea Biotec Introduces World's First Fully Liquid Hexavalent Combination Vaccine EasySixTM for Six Preventable Diseases.
29-03-2017
Bigul

Clarifies on News item

With reference to news flashed on ET Now dated March 01, 2017. "Narayana Hrudayalaya in advanced talks to buy Panacea Biotec's Gurgaon hospital." Panacea Biotec Ltd has submitted to BSE a copy of Clarification is enclosed.
01-03-2017
Bigul

Narayana Hrudayalaya confirms its looking into buying Panacea Biotec hospital

Narayana Hrudayalaya confirmed that the company is in discussions to acquire Panacea Biotec, and signed a non-binding MOU with the company in December last year. Narayana Hrudaylaya has said that due diligence is currently in progress with the firm to buy the Gurgaon hospital. Panacea Biotec's stock had risen sharply in Jan this year, on new drug approvals by the US FDA.
01-03-2017
Bigul

Clarification sought from Panacea Biotec Ltd

The Exchange has sought clarification from Panacea Biotec Ltd on March 01, 2017 with reference to news flashed on ET Now dated March 01, 2017. "Narayana Hrudayalaya in advanced talks to buy Panacea Biotec's Gurgaon hospital."The reply is awaited.
01-03-2017
Next Page
Close

Let's Open Free Demat Account